Intercept Pharmaceuticals
ICPT
$18.26
Share price
1.78%
Change (1 day)
11.41%
Change (1 year)
Earnings for Intercept Pharmaceuticals (ICPT)
Earnings in 2022 (TTM): -$0.18 B
According to Intercept Pharmaceuticals 's latest financial reports the company's current earnings (TTM) are -$0.18 B. In 2021 the company made an earning of -$91.43 M an increase over its 2020 earnings that were of -$0.28 B.The earnings displayed on this page is the company's Pretax Income.
Earnings history for Intercept Pharmaceuticals from 2012 to 2022
Annual earnings
| Year | Earnings | Change |
|---|---|---|
| 2022 (TTM) | -$0.18 B | 94.66% |
| 2021 | -$91.43 M | -66.74% |
| 2020 | -$0.28 B | -20.25% |
| 2019 | -$0.35 B | 11.46% |
| 2018 | -$0.31 B | -14.19% |
| 2017 | -$0.37 B | -12.71% |
| 2016 | -$0.42 B | 82.32% |
| 2015 | -$0.23 B | -23.21% |
| 2014 | -$0.3 B | 334.95% |
| 2013 | -$67.8 M | 60.48% |
| 2012 | -$42.25 M |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 Eli Lilly LLY | $6.54 B | -3,780.30% | 🇺🇸 USA |
 Gilead Sciences GILD | $4.54 B | -2,652.09% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | $7.71 B | -4,433.27% | 🇺🇸 USA |
 MediciNova MNOV | -$13.15 M | -92.61% | 🇺🇸 USA |